American Research & Management Company’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-16,265
| Closed | -$1.62M | – | 349 |
|
|
2019
Q3 | $1.62M | Sell |
16,265
-425
| -3% | -$42.2K | 0.49% | 53 |
|
|
2019
Q2 | $1.54M | Sell |
16,690
-720
| -4% | -$66.6K | 0.46% | 55 |
|
|
2019
Q1 | $1.64M | Hold |
17,410
| – | – | 0.47% | 51 |
|
|
2018
Q4 | $1.12M | Sell |
17,410
-7,920
| -31% | -$508K | 0.38% | 60 |
|
|
2018
Q3 | $2.27M | Buy |
25,330
+315
| +1% | +$28.2K | 0.67% | 42 |
|
|
2018
Q2 | $1.99M | Buy |
25,015
+2,770
| +12% | +$220K | 0.69% | 40 |
|
|
2018
Q1 | $1.98M | Buy |
22,245
+255
| +1% | +$22.7K | 0.65% | 42 |
|
|
2017
Q4 | $2.3M | Buy |
21,990
+1,335
| +6% | +$139K | 0.71% | 41 |
|
|
2017
Q3 | $3.01M | Buy |
20,655
+325
| +2% | +$47.4K | 0.98% | 32 |
|
|
2017
Q2 | $2.64M | Buy |
20,330
+325
| +2% | +$42.2K | 0.87% | 35 |
|
|
2017
Q1 | $2.49M | Buy |
20,005
+2,065
| +12% | +$257K | 0.89% | 33 |
|
|
2016
Q4 | $2.08M | Buy |
17,940
+105
| +0.6% | +$12.2K | 0.71% | 41 |
|
|
2016
Q3 | $1.86M | Buy |
17,835
+2,980
| +20% | +$311K | 0.68% | 44 |
|
|
2016
Q2 | $1.47M | Buy |
14,855
+5,360
| +56% | +$529K | 0.56% | 50 |
|
|
2016
Q1 | $950K | Buy |
9,495
+1,550
| +20% | +$155K | 0.4% | 58 |
|
|
2015
Q4 | $951K | Buy |
7,945
+3,975
| +100% | +$476K | 0.41% | 62 |
|
|
2015
Q3 | $429K | Buy |
+3,970
| New | +$429K | 0.19% | 82 |
|
|
2015
Q1 | – | Sell |
-50
| Closed | -$6K | – | 384 |
|
|
2014
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 314 |
|
|
2014
Q3 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 328 |
|